CD8A and cancer: By evaluating the contribution of immune cells, such as effector CD8 + T cells, B cells, NK cells, regulatory T cells (Tregs), and myelosuppressive cells, to immune activation and clinical prognosis in tumor patients in the TCGA pan-cancer dataset, we were able to derive coefficients for each immune cell.